Rohini Sen

Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)

David R. Spigel, Michael McCleod, Robert M. Jotte et al. · Journal of Thoracic Oncology · 2019 · 184 citations

Checkmate 153, Oncology, Cancer Management +8

Cancer Stage Knowledge and Desire for Information: Mismatch in Latino Cancer Patients?

Rosario Costas-Muñíz, Rohini Sen, Jennifer Leng et al. · Journal of Cancer Education · 2013 · 59 citations · Full text

Ethnicity, Culture, Latino Culture +12

P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153

David R. Spigel, Lee S. Schwartzberg, David Waterhouse et al. · Journal of Thoracic Oncology · 2017 · 52 citations · Full text

Checkmate 153, Medicine, Cancer Management +8

Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials

Deborah Elstein, Nadia Belmatoug, Patrick Deegan et al. · Orphanet Journal of Rare Diseases · 2022 · 33 citations · Full text

Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ)

Tjalf Ziemssen, Glenn Phillips, Ruchit Shah et al. · Journal of Neurology · 2016 · 21 citations

Neurological Functioning, Neurological Disorder, Disability +6